| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiration | 45 | 2026 | 275 | 11.330 |
Why?
|
| Neurons | 51 | 2026 | 1620 | 6.880 |
Why?
|
| Respiratory Center | 28 | 2025 | 52 | 6.780 |
Why?
|
| Medulla Oblongata | 19 | 2026 | 92 | 5.710 |
Why?
|
| Nerve Net | 35 | 2025 | 405 | 4.890 |
Why?
|
| Respiratory Insufficiency | 10 | 2026 | 211 | 4.790 |
Why?
|
| Respiratory Mechanics | 19 | 2014 | 109 | 3.480 |
Why?
|
| Periodicity | 17 | 2019 | 115 | 3.300 |
Why?
|
| Analgesics, Opioid | 9 | 2026 | 539 | 3.250 |
Why?
|
| Brain Stem | 19 | 2025 | 168 | 3.060 |
Why?
|
| Hypoxia | 19 | 2026 | 699 | 3.000 |
Why?
|
| Sudden Infant Death | 10 | 2024 | 36 | 2.980 |
Why?
|
| Rett Syndrome | 9 | 2026 | 21 | 2.750 |
Why?
|
| Arousal | 8 | 2026 | 177 | 2.490 |
Why?
|
| Models, Neurological | 10 | 2025 | 418 | 2.430 |
Why?
|
| Mice | 81 | 2026 | 12697 | 2.310 |
Why?
|
| Action Potentials | 23 | 2025 | 611 | 2.290 |
Why?
|
| Biological Clocks | 14 | 2011 | 74 | 2.220 |
Why?
|
| Animals | 109 | 2026 | 28902 | 2.190 |
Why?
|
| Synaptic Transmission | 15 | 2022 | 226 | 2.030 |
Why?
|
| Fentanyl | 3 | 2025 | 92 | 1.890 |
Why?
|
| Neuronal Plasticity | 9 | 2023 | 201 | 1.850 |
Why?
|
| Deglutition | 4 | 2026 | 87 | 1.750 |
Why?
|
| Inhalation | 5 | 2021 | 34 | 1.590 |
Why?
|
| Ion Channels | 6 | 2026 | 259 | 1.560 |
Why?
|
| Autonomic Nervous System Diseases | 4 | 2023 | 25 | 1.520 |
Why?
|
| Mice, Inbred C57BL | 21 | 2026 | 3598 | 1.500 |
Why?
|
| Respiration Disorders | 4 | 2022 | 42 | 1.300 |
Why?
|
| Receptors, Neurokinin-1 | 3 | 2026 | 10 | 1.300 |
Why?
|
| Optogenetics | 4 | 2025 | 47 | 1.260 |
Why?
|
| Interneurons | 6 | 2025 | 103 | 1.210 |
Why?
|
| Transcriptome | 3 | 2026 | 821 | 1.190 |
Why?
|
| Sleep Apnea, Obstructive | 4 | 2024 | 229 | 1.180 |
Why?
|
| Motor Neurons | 7 | 2025 | 192 | 1.170 |
Why?
|
| Neuroglia | 4 | 2025 | 78 | 1.170 |
Why?
|
| Neural Inhibition | 8 | 2018 | 102 | 1.150 |
Why?
|
| Calcium | 7 | 2025 | 1196 | 1.110 |
Why?
|
| Dependovirus | 3 | 2025 | 38 | 1.110 |
Why?
|
| Astrocytes | 2 | 2026 | 142 | 1.100 |
Why?
|
| Respiratory Physiological Phenomena | 4 | 2014 | 50 | 1.060 |
Why?
|
| Potassium Channel Blockers | 3 | 2025 | 62 | 1.060 |
Why?
|
| Leigh Disease | 3 | 2024 | 4 | 1.060 |
Why?
|
| Respiratory System | 8 | 2023 | 121 | 1.030 |
Why?
|
| Central Nervous System | 4 | 2018 | 144 | 0.990 |
Why?
|
| Somatostatin | 1 | 2026 | 61 | 0.970 |
Why?
|
| Larynx | 2 | 2023 | 36 | 0.950 |
Why?
|
| Brain | 9 | 2025 | 2448 | 0.920 |
Why?
|
| Isoflurane | 5 | 2025 | 58 | 0.910 |
Why?
|
| Receptors, Opioid, mu | 2 | 2025 | 50 | 0.910 |
Why?
|
| Sodium | 3 | 2025 | 330 | 0.890 |
Why?
|
| Anesthetics, Inhalation | 5 | 2025 | 98 | 0.890 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 2 | 2025 | 89 | 0.880 |
Why?
|
| Animals, Newborn | 19 | 2021 | 524 | 0.880 |
Why?
|
| In Vitro Techniques | 23 | 2014 | 945 | 0.880 |
Why?
|
| Mice, Transgenic | 13 | 2025 | 1604 | 0.870 |
Why?
|
| Rabies virus | 1 | 2024 | 6 | 0.870 |
Why?
|
| Neocortex | 6 | 2012 | 100 | 0.860 |
Why?
|
| Efferent Pathways | 1 | 2024 | 22 | 0.860 |
Why?
|
| Oxygen | 7 | 2023 | 801 | 0.840 |
Why?
|
| Long-Term Potentiation | 2 | 2023 | 51 | 0.820 |
Why?
|
| Central Pattern Generators | 2 | 2021 | 4 | 0.810 |
Why?
|
| Oligodendroglia | 1 | 2024 | 78 | 0.800 |
Why?
|
| Whole Genome Sequencing | 1 | 2024 | 117 | 0.790 |
Why?
|
| Autonomic Nervous System | 3 | 2023 | 70 | 0.790 |
Why?
|
| Morphine | 1 | 2023 | 127 | 0.750 |
Why?
|
| Mammals | 3 | 2018 | 268 | 0.740 |
Why?
|
| Neurodegenerative Diseases | 1 | 2023 | 59 | 0.740 |
Why?
|
| Neurotransmitter Agents | 3 | 2019 | 102 | 0.730 |
Why?
|
| Nervous System Diseases | 1 | 2023 | 169 | 0.720 |
Why?
|
| Humans | 63 | 2026 | 98135 | 0.710 |
Why?
|
| Electron Transport Complex I | 7 | 2025 | 36 | 0.710 |
Why?
|
| Sneezing | 1 | 2022 | 36 | 0.710 |
Why?
|
| Carbon Dioxide | 2 | 2026 | 202 | 0.690 |
Why?
|
| Patch-Clamp Techniques | 14 | 2025 | 381 | 0.680 |
Why?
|
| Neural Pathways | 5 | 2025 | 332 | 0.660 |
Why?
|
| Hypoxia, Brain | 4 | 2018 | 41 | 0.650 |
Why?
|
| Substance P | 6 | 2026 | 62 | 0.640 |
Why?
|
| Emotions | 2 | 2022 | 387 | 0.640 |
Why?
|
| Male | 42 | 2026 | 47109 | 0.630 |
Why?
|
| Neurophysiology | 1 | 2020 | 14 | 0.630 |
Why?
|
| Oxygen Consumption | 3 | 2010 | 239 | 0.630 |
Why?
|
| Sodium Channels | 7 | 2012 | 131 | 0.620 |
Why?
|
| Editorial Policies | 1 | 2020 | 37 | 0.610 |
Why?
|
| Substantia Nigra | 3 | 2025 | 28 | 0.610 |
Why?
|
| Vesicular Glutamate Transport Protein 2 | 4 | 2026 | 7 | 0.540 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 473 | 0.540 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 5 | 2026 | 18 | 0.540 |
Why?
|
| Periodicals as Topic | 1 | 2020 | 175 | 0.540 |
Why?
|
| Calcium Channels | 4 | 2007 | 180 | 0.530 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2024 | 2555 | 0.510 |
Why?
|
| Synapses | 5 | 2016 | 280 | 0.510 |
Why?
|
| Opioid-Related Disorders | 1 | 2021 | 255 | 0.500 |
Why?
|
| Disease Models, Animal | 10 | 2026 | 2572 | 0.500 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2018 | 195 | 0.500 |
Why?
|
| Wakefulness | 3 | 2026 | 130 | 0.490 |
Why?
|
| Neurogenesis | 5 | 2019 | 93 | 0.480 |
Why?
|
| Infant | 11 | 2024 | 3332 | 0.480 |
Why?
|
| Dentate Gyrus | 4 | 2021 | 34 | 0.480 |
Why?
|
| Child | 14 | 2023 | 7699 | 0.480 |
Why?
|
| Respiratory Burst | 3 | 2006 | 19 | 0.480 |
Why?
|
| Female | 40 | 2026 | 51570 | 0.460 |
Why?
|
| Hippocampus | 2 | 2011 | 466 | 0.460 |
Why?
|
| Pulmonary Ventilation | 2 | 2013 | 32 | 0.450 |
Why?
|
| Environmental Exposure | 1 | 2018 | 405 | 0.440 |
Why?
|
| Dinoprostone | 2 | 2014 | 80 | 0.430 |
Why?
|
| Peripheral Nervous System | 2 | 2026 | 21 | 0.420 |
Why?
|
| Organ Culture Techniques | 7 | 2021 | 120 | 0.420 |
Why?
|
| Lip | 1 | 2014 | 17 | 0.420 |
Why?
|
| Seizures | 3 | 2022 | 324 | 0.400 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2013 | 33 | 0.380 |
Why?
|
| Polysomnography | 3 | 2013 | 154 | 0.380 |
Why?
|
| Calcium Channels, N-Type | 1 | 2013 | 40 | 0.380 |
Why?
|
| Norepinephrine | 3 | 2014 | 167 | 0.380 |
Why?
|
| Deglutition Disorders | 2 | 2026 | 126 | 0.370 |
Why?
|
| Hyperthermia, Induced | 2 | 2004 | 77 | 0.370 |
Why?
|
| Sex Characteristics | 2 | 2020 | 351 | 0.350 |
Why?
|
| Parkinson Disease | 2 | 2025 | 187 | 0.350 |
Why?
|
| Homeodomain Proteins | 4 | 2025 | 566 | 0.350 |
Why?
|
| Invertebrates | 1 | 2011 | 36 | 0.340 |
Why?
|
| Pyramidal Cells | 4 | 2016 | 84 | 0.340 |
Why?
|
| Oxidants | 1 | 2011 | 86 | 0.340 |
Why?
|
| Lung Diseases | 1 | 2013 | 284 | 0.330 |
Why?
|
| Infant, Premature | 1 | 2013 | 306 | 0.330 |
Why?
|
| Tetrodotoxin | 7 | 2012 | 49 | 0.330 |
Why?
|
| Cholinergic Neurons | 2 | 2024 | 14 | 0.330 |
Why?
|
| Hydrogen Peroxide | 1 | 2011 | 173 | 0.330 |
Why?
|
| Adaptation, Physiological | 3 | 2008 | 349 | 0.320 |
Why?
|
| Vertebrates | 1 | 2011 | 115 | 0.320 |
Why?
|
| Flufenamic Acid | 6 | 2014 | 11 | 0.300 |
Why?
|
| Excitatory Postsynaptic Potentials | 5 | 2018 | 87 | 0.300 |
Why?
|
| Infant, Newborn | 7 | 2024 | 2531 | 0.300 |
Why?
|
| Sleep | 3 | 2022 | 469 | 0.300 |
Why?
|
| Seals, Earless | 1 | 2008 | 1 | 0.290 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2008 | 26 | 0.290 |
Why?
|
| Prosencephalon | 2 | 2025 | 70 | 0.280 |
Why?
|
| Behavior, Animal | 1 | 2011 | 399 | 0.270 |
Why?
|
| Dopaminergic Neurons | 2 | 2025 | 32 | 0.260 |
Why?
|
| Riluzole | 5 | 2014 | 15 | 0.260 |
Why?
|
| Homeostasis | 3 | 2018 | 474 | 0.250 |
Why?
|
| Epilepsy | 3 | 2022 | 447 | 0.250 |
Why?
|
| Biophysics | 3 | 2019 | 154 | 0.250 |
Why?
|
| Tachykinins | 2 | 2026 | 14 | 0.240 |
Why?
|
| Retinal Dehydrogenase | 1 | 2026 | 8 | 0.240 |
Why?
|
| Electric Stimulation | 5 | 2011 | 346 | 0.240 |
Why?
|
| Mice, Knockout | 8 | 2026 | 2207 | 0.240 |
Why?
|
| Respiratory Rate | 3 | 2023 | 27 | 0.240 |
Why?
|
| Transcription Factors | 3 | 2025 | 1717 | 0.240 |
Why?
|
| Heart Rate | 3 | 2012 | 536 | 0.240 |
Why?
|
| Psychophysiology | 2 | 2022 | 9 | 0.230 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 4 | 2012 | 92 | 0.230 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2006 | 50 | 0.230 |
Why?
|
| Toxins, Biological | 1 | 2025 | 9 | 0.230 |
Why?
|
| Acetylcholine | 2 | 2019 | 158 | 0.220 |
Why?
|
| NAV1.1 Voltage-Gated Sodium Channel | 1 | 2025 | 11 | 0.220 |
Why?
|
| Antiparkinson Agents | 1 | 2025 | 18 | 0.220 |
Why?
|
| Diaphragm | 1 | 2025 | 76 | 0.220 |
Why?
|
| Child, Preschool | 7 | 2020 | 4006 | 0.220 |
Why?
|
| Neuroanatomical Tract-Tracing Techniques | 1 | 2024 | 2 | 0.220 |
Why?
|
| Levodopa | 1 | 2025 | 39 | 0.220 |
Why?
|
| Birds | 1 | 2007 | 178 | 0.220 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2025 | 26 | 0.210 |
Why?
|
| Afferent Pathways | 1 | 2024 | 62 | 0.210 |
Why?
|
| Genetic Therapy | 2 | 2025 | 373 | 0.200 |
Why?
|
| Intellectual Disability | 2 | 2022 | 202 | 0.200 |
Why?
|
| Computer Simulation | 2 | 2025 | 1153 | 0.200 |
Why?
|
| Murinae | 1 | 2023 | 5 | 0.200 |
Why?
|
| Cadmium | 5 | 2014 | 30 | 0.200 |
Why?
|
| Evoked Potentials | 2 | 2013 | 200 | 0.200 |
Why?
|
| Stillbirth | 1 | 2023 | 15 | 0.200 |
Why?
|
| Albuterol | 1 | 2023 | 36 | 0.200 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2025 | 127 | 0.200 |
Why?
|
| Oxazines | 1 | 2023 | 18 | 0.200 |
Why?
|
| Exhalation | 1 | 2023 | 13 | 0.200 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2023 | 18 | 0.200 |
Why?
|
| Epinephrine | 1 | 2023 | 92 | 0.200 |
Why?
|
| Bronchodilator Agents | 1 | 2023 | 72 | 0.190 |
Why?
|
| Cranial Nerve Diseases | 1 | 2023 | 10 | 0.190 |
Why?
|
| Excitatory Amino Acid Antagonists | 5 | 2011 | 78 | 0.190 |
Why?
|
| Risk Factors | 7 | 2024 | 6232 | 0.190 |
Why?
|
| Fetal Growth Retardation | 1 | 2023 | 73 | 0.190 |
Why?
|
| Sleep Apnea, Central | 1 | 2023 | 17 | 0.190 |
Why?
|
| Gonorrhea | 1 | 2023 | 24 | 0.190 |
Why?
|
| Receptors, Serotonin | 1 | 2002 | 34 | 0.190 |
Why?
|
| Consciousness Disorders | 1 | 2023 | 14 | 0.190 |
Why?
|
| Circadian Rhythm | 2 | 2020 | 295 | 0.190 |
Why?
|
| Coma | 1 | 2023 | 46 | 0.190 |
Why?
|
| Caenorhabditis elegans | 1 | 2025 | 256 | 0.190 |
Why?
|
| Electrophysiology | 5 | 2008 | 389 | 0.190 |
Why?
|
| Gene Frequency | 1 | 2024 | 715 | 0.180 |
Why?
|
| Fever | 1 | 2003 | 122 | 0.180 |
Why?
|
| Protein Precursors | 1 | 2002 | 133 | 0.180 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 2021 | 21 | 0.180 |
Why?
|
| Hypoglossal Nerve | 2 | 2013 | 28 | 0.180 |
Why?
|
| Signal Transduction | 5 | 2026 | 3621 | 0.170 |
Why?
|
| Abnormalities, Multiple | 1 | 2023 | 235 | 0.170 |
Why?
|
| Sodium Channel Blockers | 5 | 2014 | 27 | 0.170 |
Why?
|
| Drug Interactions | 4 | 2011 | 239 | 0.170 |
Why?
|
| Heat-Shock Response | 1 | 2002 | 55 | 0.170 |
Why?
|
| Parkinsonian Disorders | 1 | 2021 | 24 | 0.170 |
Why?
|
| Hepatitis C | 1 | 2023 | 186 | 0.160 |
Why?
|
| Smoking | 3 | 2020 | 674 | 0.160 |
Why?
|
| Heat-Shock Proteins | 1 | 2002 | 178 | 0.160 |
Why?
|
| Cytoskeletal Proteins | 1 | 2021 | 225 | 0.160 |
Why?
|
| Dysautonomia, Familial | 2 | 2011 | 2 | 0.160 |
Why?
|
| Skin | 1 | 2023 | 592 | 0.160 |
Why?
|
| Pregnancy | 6 | 2024 | 3244 | 0.150 |
Why?
|
| Strychnine | 2 | 2018 | 8 | 0.150 |
Why?
|
| Time Factors | 5 | 2016 | 5576 | 0.150 |
Why?
|
| Serotonin Antagonists | 3 | 2010 | 24 | 0.140 |
Why?
|
| Case-Control Studies | 4 | 2023 | 1996 | 0.140 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 2 | 2010 | 6 | 0.140 |
Why?
|
| Cluster Analysis | 3 | 2017 | 402 | 0.140 |
Why?
|
| Lung | 1 | 2005 | 1407 | 0.140 |
Why?
|
| Vagotomy | 1 | 2018 | 12 | 0.140 |
Why?
|
| Cerebral Cortex | 3 | 2021 | 583 | 0.140 |
Why?
|
| Pyridazines | 1 | 2018 | 25 | 0.140 |
Why?
|
| Diving | 2 | 2008 | 5 | 0.130 |
Why?
|
| Nonlinear Dynamics | 1 | 2018 | 68 | 0.130 |
Why?
|
| Plethysmography | 2 | 2008 | 16 | 0.130 |
Why?
|
| Mitochondria | 2 | 2025 | 650 | 0.130 |
Why?
|
| HEK293 Cells | 3 | 2025 | 721 | 0.130 |
Why?
|
| Feedback, Physiological | 1 | 2018 | 71 | 0.130 |
Why?
|
| Oxidative Stress | 1 | 2020 | 489 | 0.130 |
Why?
|
| Peptides | 1 | 2021 | 669 | 0.130 |
Why?
|
| Genetic Variation | 1 | 2024 | 1445 | 0.130 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 3 | 2011 | 13 | 0.130 |
Why?
|
| Pregnancy Outcome | 1 | 2019 | 277 | 0.130 |
Why?
|
| Cell Hypoxia | 2 | 2008 | 191 | 0.130 |
Why?
|
| RNA | 1 | 2021 | 595 | 0.130 |
Why?
|
| Infant Mortality | 3 | 2023 | 68 | 0.120 |
Why?
|
| Neural Stem Cells | 2 | 2018 | 73 | 0.120 |
Why?
|
| Mice, Inbred Strains | 3 | 2012 | 281 | 0.120 |
Why?
|
| Cognition | 1 | 2022 | 673 | 0.120 |
Why?
|
| United States | 7 | 2024 | 8193 | 0.120 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2016 | 42 | 0.120 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2016 | 85 | 0.120 |
Why?
|
| GABA Antagonists | 3 | 2011 | 26 | 0.120 |
Why?
|
| Mutation | 3 | 2013 | 4392 | 0.120 |
Why?
|
| Glutamine | 1 | 2016 | 98 | 0.120 |
Why?
|
| Encephalitis | 1 | 2015 | 46 | 0.110 |
Why?
|
| Cocaine | 1 | 2016 | 84 | 0.110 |
Why?
|
| Nucleus Accumbens | 1 | 2016 | 117 | 0.110 |
Why?
|
| Smoking Cessation | 1 | 2019 | 306 | 0.110 |
Why?
|
| Progesterone | 1 | 2015 | 126 | 0.110 |
Why?
|
| Potassium | 3 | 2004 | 230 | 0.110 |
Why?
|
| Neoplastic Stem Cells | 1 | 2017 | 189 | 0.110 |
Why?
|
| Retrospective Studies | 4 | 2023 | 10962 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2016 | 1950 | 0.110 |
Why?
|
| Cell Nucleus | 1 | 2017 | 615 | 0.110 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 2 | 2011 | 14 | 0.100 |
Why?
|
| Cells, Cultured | 4 | 2025 | 2855 | 0.100 |
Why?
|
| Glioblastoma | 1 | 2017 | 299 | 0.100 |
Why?
|
| N-Methylaspartate | 2 | 2010 | 45 | 0.100 |
Why?
|
| Excitatory Amino Acid Agonists | 2 | 2010 | 43 | 0.100 |
Why?
|
| Membrane Potentials | 3 | 2005 | 406 | 0.100 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2013 | 68 | 0.100 |
Why?
|
| Phrenic Nerve | 1 | 2013 | 49 | 0.100 |
Why?
|
| KATP Channels | 1 | 2013 | 18 | 0.100 |
Why?
|
| Calcium Channels, Q-Type | 1 | 2013 | 6 | 0.100 |
Why?
|
| Calcium Channels, P-Type | 1 | 2013 | 8 | 0.100 |
Why?
|
| Mice, 129 Strain | 1 | 2013 | 55 | 0.100 |
Why?
|
| Ketanserin | 2 | 2010 | 9 | 0.100 |
Why?
|
| Sleep Apnea Syndromes | 2 | 2018 | 109 | 0.100 |
Why?
|
| Adenosine Triphosphate | 2 | 2025 | 319 | 0.100 |
Why?
|
| Stress, Psychological | 1 | 2016 | 383 | 0.090 |
Why?
|
| Piperazines | 2 | 2011 | 306 | 0.090 |
Why?
|
| Microglia | 2 | 2015 | 131 | 0.090 |
Why?
|
| Integrases | 1 | 2012 | 68 | 0.090 |
Why?
|
| Gap Junctions | 2 | 2017 | 146 | 0.090 |
Why?
|
| Picrotoxin | 1 | 2011 | 7 | 0.090 |
Why?
|
| Deferoxamine | 1 | 2011 | 19 | 0.090 |
Why?
|
| Ferrous Compounds | 1 | 2011 | 18 | 0.090 |
Why?
|
| Malondialdehyde | 1 | 2011 | 27 | 0.090 |
Why?
|
| Siderophores | 1 | 2011 | 21 | 0.090 |
Why?
|
| Synaptic Potentials | 1 | 2011 | 16 | 0.090 |
Why?
|
| T-Box Domain Proteins | 1 | 2013 | 139 | 0.090 |
Why?
|
| Lipid Peroxidation | 1 | 2011 | 46 | 0.090 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2011 | 9 | 0.090 |
Why?
|
| Cardiovascular System | 1 | 2011 | 52 | 0.090 |
Why?
|
| Piperidines | 2 | 2010 | 172 | 0.090 |
Why?
|
| Motor Activity | 2 | 2016 | 331 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 1394 | 0.080 |
Why?
|
| TRPM Cation Channels | 1 | 2011 | 8 | 0.080 |
Why?
|
| Egtazic Acid | 1 | 2011 | 32 | 0.080 |
Why?
|
| Phenanthrenes | 1 | 2011 | 4 | 0.080 |
Why?
|
| Transient Receptor Potential Channels | 1 | 2011 | 5 | 0.080 |
Why?
|
| Age Factors | 3 | 2019 | 1967 | 0.080 |
Why?
|
| Chelating Agents | 1 | 2011 | 68 | 0.080 |
Why?
|
| Light | 1 | 2012 | 290 | 0.080 |
Why?
|
| Brain Neoplasms | 1 | 2017 | 842 | 0.080 |
Why?
|
| Mice, Mutant Strains | 2 | 2019 | 217 | 0.080 |
Why?
|
| Calcium Channel Blockers | 2 | 2014 | 118 | 0.080 |
Why?
|
| Serotonin 5-HT2 Receptor Antagonists | 1 | 2010 | 6 | 0.080 |
Why?
|
| Neurokinin-1 Receptor Antagonists | 1 | 2010 | 12 | 0.080 |
Why?
|
| Isoindoles | 1 | 2010 | 13 | 0.080 |
Why?
|
| Adrenergic alpha-1 Receptor Antagonists | 1 | 2010 | 8 | 0.080 |
Why?
|
| Receptors, Serotonin, 5-HT2 | 1 | 2010 | 14 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2013 | 668 | 0.080 |
Why?
|
| Locus Coeruleus | 1 | 2010 | 7 | 0.080 |
Why?
|
| Anesthetics, Local | 2 | 2010 | 85 | 0.080 |
Why?
|
| Microinjections | 1 | 2010 | 67 | 0.080 |
Why?
|
| Asphyxia | 2 | 2020 | 13 | 0.080 |
Why?
|
| Raphe Nuclei | 1 | 2010 | 37 | 0.080 |
Why?
|
| Mutation, Missense | 2 | 2022 | 302 | 0.070 |
Why?
|
| Dopamine | 1 | 2011 | 280 | 0.070 |
Why?
|
| Adult | 3 | 2024 | 29564 | 0.070 |
Why?
|
| Electromyography | 1 | 2010 | 235 | 0.070 |
Why?
|
| Data Interpretation, Statistical | 2 | 2012 | 313 | 0.070 |
Why?
|
| Cohort Studies | 3 | 2024 | 3213 | 0.070 |
Why?
|
| Finches | 1 | 2009 | 65 | 0.070 |
Why?
|
| Genetic Vectors | 2 | 2025 | 426 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2011 | 358 | 0.070 |
Why?
|
| Presenilin-1 | 1 | 2008 | 97 | 0.070 |
Why?
|
| Regional Blood Flow | 1 | 2008 | 194 | 0.070 |
Why?
|
| Vocalization, Animal | 1 | 2009 | 111 | 0.070 |
Why?
|
| Biological Evolution | 1 | 2016 | 1072 | 0.070 |
Why?
|
| Aging | 1 | 2013 | 771 | 0.070 |
Why?
|
| Cell Survival | 2 | 2017 | 1014 | 0.060 |
Why?
|
| Hibernation | 1 | 2007 | 5 | 0.060 |
Why?
|
| Species Specificity | 1 | 2008 | 690 | 0.060 |
Why?
|
| Cell Membrane | 3 | 2004 | 673 | 0.060 |
Why?
|
| Cerebrovascular Circulation | 1 | 2008 | 239 | 0.060 |
Why?
|
| Death, Sudden | 1 | 2006 | 44 | 0.060 |
Why?
|
| Respiratory System Abnormalities | 1 | 2005 | 5 | 0.060 |
Why?
|
| Hypercapnia | 1 | 2026 | 51 | 0.060 |
Why?
|
| Stem Cells | 1 | 2008 | 395 | 0.060 |
Why?
|
| Reflex | 1 | 2026 | 82 | 0.060 |
Why?
|
| Visual Cortex | 1 | 2008 | 254 | 0.060 |
Why?
|
| Cadmium Chloride | 1 | 2005 | 12 | 0.060 |
Why?
|
| Cations | 1 | 2025 | 29 | 0.060 |
Why?
|
| Nifedipine | 1 | 2005 | 24 | 0.060 |
Why?
|
| Tetraethylammonium | 1 | 2005 | 24 | 0.060 |
Why?
|
| Environment | 1 | 2007 | 233 | 0.050 |
Why?
|
| Analysis of Variance | 3 | 2013 | 889 | 0.050 |
Why?
|
| Cell Proliferation | 3 | 2018 | 1790 | 0.050 |
Why?
|
| Lipid Bilayers | 1 | 2025 | 148 | 0.050 |
Why?
|
| Cholinergic Agents | 1 | 2024 | 18 | 0.050 |
Why?
|
| Decerebrate State | 1 | 2003 | 4 | 0.050 |
Why?
|
| Animal Experimentation | 1 | 2003 | 9 | 0.050 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2003 | 19 | 0.050 |
Why?
|
| Hawaii | 1 | 2023 | 27 | 0.050 |
Why?
|
| Halothane | 1 | 2023 | 5 | 0.050 |
Why?
|
| Electrocardiography | 1 | 2006 | 527 | 0.050 |
Why?
|
| National Institute of Neurological Disorders and Stroke (U.S.) | 1 | 2023 | 2 | 0.050 |
Why?
|
| Carotid Body | 1 | 2026 | 246 | 0.050 |
Why?
|
| Fluoxetine | 1 | 2023 | 43 | 0.050 |
Why?
|
| Serotonin Receptor Agonists | 1 | 2002 | 14 | 0.050 |
Why?
|
| Positive-Pressure Respiration | 1 | 2023 | 55 | 0.050 |
Why?
|
| Consciousness | 1 | 2023 | 28 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2008 | 646 | 0.050 |
Why?
|
| Electric Conductivity | 1 | 2002 | 144 | 0.050 |
Why?
|
| Ion Channel Gating | 1 | 2025 | 318 | 0.050 |
Why?
|
| Spinal Cord | 1 | 2024 | 244 | 0.050 |
Why?
|
| KCNQ Potassium Channels | 1 | 2022 | 7 | 0.050 |
Why?
|
| Death | 1 | 2023 | 98 | 0.050 |
Why?
|
| Gestational Age | 1 | 2023 | 341 | 0.050 |
Why?
|
| Cricetulus | 1 | 2022 | 123 | 0.050 |
Why?
|
| HSC70 Heat-Shock Proteins | 1 | 2002 | 5 | 0.040 |
Why?
|
| HSP72 Heat-Shock Proteins | 1 | 2002 | 24 | 0.040 |
Why?
|
| Hepacivirus | 1 | 2023 | 137 | 0.040 |
Why?
|
| Potassium Channels | 1 | 2024 | 349 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2002 | 267 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2023 | 271 | 0.040 |
Why?
|
| Cricetinae | 1 | 2022 | 533 | 0.040 |
Why?
|
| Models, Biological | 1 | 2008 | 1809 | 0.040 |
Why?
|
| Endocytosis | 1 | 2022 | 187 | 0.040 |
Why?
|
| Reference Values | 1 | 2002 | 612 | 0.040 |
Why?
|
| Pregnancy Complications | 1 | 2024 | 365 | 0.040 |
Why?
|
| Temperature | 1 | 2003 | 442 | 0.040 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2002 | 119 | 0.040 |
Why?
|
| Infant Care | 1 | 2020 | 8 | 0.040 |
Why?
|
| Supine Position | 1 | 2020 | 34 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2024 | 850 | 0.040 |
Why?
|
| Prone Position | 1 | 2020 | 64 | 0.040 |
Why?
|
| Geography, Medical | 1 | 2020 | 2 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2021 | 353 | 0.040 |
Why?
|
| Kinetics | 1 | 2002 | 1476 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2002 | 370 | 0.040 |
Why?
|
| Respiration, Artificial | 1 | 2003 | 462 | 0.040 |
Why?
|
| Beds | 1 | 2019 | 7 | 0.040 |
Why?
|
| Monitoring, Ambulatory | 2 | 2011 | 32 | 0.040 |
Why?
|
| Genes, X-Linked | 1 | 2020 | 39 | 0.040 |
Why?
|
| Exons | 1 | 2021 | 451 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 993 | 0.040 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2019 | 25 | 0.040 |
Why?
|
| Bicuculline | 2 | 2010 | 18 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2023 | 522 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2020 | 84 | 0.040 |
Why?
|
| Stress, Physiological | 1 | 2002 | 256 | 0.040 |
Why?
|
| Recombinases | 1 | 2019 | 22 | 0.040 |
Why?
|
| Reactive Nitrogen Species | 1 | 2018 | 9 | 0.040 |
Why?
|
| Glucose | 1 | 2022 | 704 | 0.040 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2018 | 30 | 0.040 |
Why?
|
| Free Radical Scavengers | 1 | 2018 | 59 | 0.040 |
Why?
|
| Confidence Intervals | 1 | 2019 | 220 | 0.040 |
Why?
|
| Maternal Behavior | 1 | 2019 | 56 | 0.040 |
Why?
|
| Cause of Death | 1 | 2019 | 278 | 0.040 |
Why?
|
| Neuropeptides | 1 | 2018 | 113 | 0.030 |
Why?
|
| GABA-A Receptor Antagonists | 2 | 2010 | 14 | 0.030 |
Why?
|
| Phenotype | 1 | 2025 | 2638 | 0.030 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2019 | 183 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2018 | 186 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2019 | 174 | 0.030 |
Why?
|
| Self Report | 1 | 2019 | 355 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2018 | 332 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2019 | 726 | 0.030 |
Why?
|
| Adolescent | 4 | 2011 | 10097 | 0.030 |
Why?
|
| Miniature Postsynaptic Potentials | 1 | 2016 | 6 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 916 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2021 | 829 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 256 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2016 | 81 | 0.030 |
Why?
|
| Glycine Agents | 2 | 2008 | 5 | 0.030 |
Why?
|
| Acoustic Stimulation | 1 | 2016 | 130 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2020 | 601 | 0.030 |
Why?
|
| Logistic Models | 1 | 2019 | 1275 | 0.030 |
Why?
|
| Bradykinin | 1 | 2014 | 45 | 0.030 |
Why?
|
| Receptors, Glutamate | 1 | 2014 | 22 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2019 | 1090 | 0.030 |
Why?
|
| Incidence | 1 | 2019 | 1777 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2015 | 313 | 0.030 |
Why?
|
| Ganglia, Spinal | 1 | 2014 | 75 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2013 | 1646 | 0.030 |
Why?
|
| Receptors, Cholinergic | 1 | 2014 | 76 | 0.030 |
Why?
|
| Histamine | 1 | 2014 | 116 | 0.030 |
Why?
|
| Photic Stimulation | 1 | 2016 | 527 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 2037 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2017 | 1527 | 0.020 |
Why?
|
| Nestin | 1 | 2013 | 17 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2013 | 53 | 0.020 |
Why?
|
| Intermediate Filament Proteins | 1 | 2013 | 35 | 0.020 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2013 | 67 | 0.020 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2013 | 34 | 0.020 |
Why?
|
| Stem Cell Niche | 1 | 2013 | 24 | 0.020 |
Why?
|
| Receptors, CXCR4 | 1 | 2013 | 49 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 2023 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 220 | 0.020 |
Why?
|
| Plethysmography, Whole Body | 1 | 2012 | 9 | 0.020 |
Why?
|
| Microscopy, Video | 1 | 2012 | 36 | 0.020 |
Why?
|
| Gliosis | 1 | 2012 | 32 | 0.020 |
Why?
|
| Vestibular Nuclei | 1 | 2012 | 28 | 0.020 |
Why?
|
| Halorhodopsins | 1 | 2012 | 6 | 0.020 |
Why?
|
| Proton Pumps | 1 | 2012 | 6 | 0.020 |
Why?
|
| Mice, Inbred ICR | 1 | 2012 | 76 | 0.020 |
Why?
|
| Channelrhodopsins | 1 | 2012 | 8 | 0.020 |
Why?
|
| Optics and Photonics | 1 | 2012 | 26 | 0.020 |
Why?
|
| GATA3 Transcription Factor | 1 | 2012 | 53 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 310 | 0.020 |
Why?
|
| Electrophysiological Phenomena | 1 | 2012 | 51 | 0.020 |
Why?
|
| Apnea | 1 | 2012 | 36 | 0.020 |
Why?
|
| Rhombencephalon | 1 | 2012 | 48 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2013 | 176 | 0.020 |
Why?
|
| Archaeal Proteins | 1 | 2012 | 26 | 0.020 |
Why?
|
| Electroporation | 1 | 2012 | 61 | 0.020 |
Why?
|
| Cell Count | 1 | 2012 | 195 | 0.020 |
Why?
|
| Vagus Nerve | 1 | 2011 | 46 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2012 | 306 | 0.020 |
Why?
|
| RNA, Untranslated | 1 | 2012 | 70 | 0.020 |
Why?
|
| Magnesium | 1 | 2012 | 175 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2012 | 142 | 0.020 |
Why?
|
| Adrenergic alpha-2 Receptor Antagonists | 1 | 2011 | 3 | 0.020 |
Why?
|
| Serotonin 5-HT2 Receptor Agonists | 1 | 2011 | 3 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 285 | 0.020 |
Why?
|
| Animals, Outbred Strains | 1 | 2011 | 17 | 0.020 |
Why?
|
| Sympathetic Nervous System | 1 | 2011 | 100 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2019 | 2585 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2013 | 428 | 0.020 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2010 | 39 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 312 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 1566 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 2888 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 512 | 0.020 |
Why?
|
| Cholinergic Fibers | 1 | 2009 | 23 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 632 | 0.020 |
Why?
|
| Neurochemistry | 1 | 2009 | 3 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2009 | 28 | 0.020 |
Why?
|
| Prognosis | 1 | 2017 | 4116 | 0.020 |
Why?
|
| Oxotremorine | 1 | 2008 | 4 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2008 | 98 | 0.020 |
Why?
|
| Muscarinic Agonists | 1 | 2008 | 22 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2008 | 370 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2008 | 303 | 0.020 |
Why?
|
| Social Environment | 1 | 2008 | 199 | 0.020 |
Why?
|
| Proteins | 1 | 2012 | 804 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 2373 | 0.010 |
Why?
|
| Heart | 1 | 2008 | 527 | 0.010 |
Why?
|
| Lanthanum | 1 | 2004 | 16 | 0.010 |
Why?
|
| Disease Progression | 1 | 2009 | 1610 | 0.010 |
Why?
|
| Receptors, GABA-A | 1 | 2004 | 37 | 0.010 |
Why?
|
| Cytokines | 1 | 2008 | 889 | 0.010 |
Why?
|
| Receptors, Glycine | 1 | 2004 | 13 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 9713 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2002 | 272 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 21760 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 3618 | 0.010 |
Why?
|